Sin conexión a internet: se muestra la versión guardada de la página.

Evotec SE

DEEUR
← Al screener

Evotec SE (XETRA:EVT) — Biotechnology: Pharmaceutical Preparations. Número de bolsas en las que cotizan las acciones de la empresa: 3. En esta página: cotización y gráfico, dividendos, principales accionistas e historial del número de acciones.

Sobre la empresa

Sitio web
evotec.com
Relaciones con los inversores
evotec.com/ir-news/investor-relations
Sector
Health Care · Biotechnology: Pharmaceutical Preparations
Sede central
HAMBURG, Germany
Consejero delegado
Dr. Christian Wojczewski Ph.D.
Empleados
4 461
Cotiza desde
12.11.1999 (XETRA:EVT)
Acciones en circulación
177.69 M
Capital flotante
135.49 M
Capitalización bursátil
521.36 M EUR
Insiders
9.97%
Inversores institucionales
60.05%
Industria (SIC)
Pharmaceutical Preparations
Descripción

Evotec SE operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally. It operates in two segments, Shared R&D and Just – Evotec Biologics. The company is developing pharmaceutical products in various therapeutic areas, such as oncology, autoimmune, cancer, diabetes, heart failure, immunology, pain and inflammation, infectious, kidney, liver, respiratory, fibrotic and metabolic diseases, and rare diseases. It is also developingcentral nervous system (CNS) and cardiometabolic diseases; and animal and women health. The company has collaboration agreements with Mass General Brigham and Joslin Diabetes Center focusing on cardiometabolic diseases; BMS antiviral; Novo Nordisk cell therapy; University of Oxford; German Cancer Research Center; University Hospital in Hamburg; University of Toronto, Harvard, and Yale; Johns Hopkins University; Ospedale San Raffaele (OSR); and National University of Singapore. In addition, it has a partnership with LAB282, LAB150, beLAB2122, beLAB1407, LAB eN², Danube Labs, VC Amplitude Ventures, LaB eN2, and 65LAB. Further, the company serves pharma and biotechnology companies, academic institutions, patient advocacy groups, and venture capital. Evotec SE has strategic collaboration with Almirall, S.A. for the development of novel therapeutics for severe skin diseases, including a range of immune-mediated inflammatory conditions. The company collaborate with Odyssey Therapeutics, Inc. to designs and develops AI based discovery platform to discover new treatments in autoimmune and inflammatory diseases. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.

Bolsas y tickers

BolsaTickerMonedaPrecioTipo
XETRA XetraEVT principalEUR3.028 -2.32%acciones ordinarias
LSE London Stock Exchange0IRF IOBEUR25.98 +0.00%acciones ordinarias
US USA StocksEVOTF OTCUSD3.325 -50.30%acciones ordinarias

Precio en 3 meses

XETRA:EVT · EUR
día alcista día bajista fecha ex-dividendo fecha de pagoPasa el cursor / toca un día — precios de apertura, cierre, máximo y mínimo

Dividendos

No se han encontrado pagos de dividendos (comprobado el 08.10.2026). Es probable que la empresa no reparta dividendos.

Noticias de esta semana

No hay noticias en la última semana. Últimas noticias: 29.09.2026.

anuncio

Principales accionistas

TitularParticipaciónAccionesFecha del informe
First TRT Exch-Trd Fd.-F…1.46%2.6 M2026-06-30
VANGUARD STAR FUNDS-Vang…1.31%2.32 M2026-07-31
Brown Capital Mgmt Mutua…1.12%2 M2026-06-30
VANGUARD TAX-MANAGED FUN…0.87%1.55 M2026-06-30
iShares Trust-iShares Co…0.62%1.1 M2026-08-31
VANGUARD Intl Eqy. INDEX…0.37%660 9782026-07-31
DCF Advisers, LLC0.33%1.08 M2026-06-30
JNL Series Trust-JNL Mul…0.3%530 5352026-06-30
DFA INVESTMENT DIMENSION…0.27%477 8302026-07-31
iShares Trust-iShares MS…0.26%469 7002026-08-31
DFA INVESTMENT DIMENSION…0.23%414 2812026-07-31
WCM Investment Managemen…0.2%671 8842026-06-30
ABC Arbitrage SA0.11%371 9362026-06-30
Optiver Holding B.v.0.1%322 1532026-06-30
Morgan Stanley0.06%205 7632026-06-30
LPL Financial LLC0.05%166 0452026-06-30
Envestnet Asset Manageme…0.04%139 5962026-06-30
Old Mission Capital, LLC0.01%38 0322026-06-30
Pathstone Holdings, LLC0.01%35 7792026-06-30
Fore Capital, LLC0.01%31 3552026-06-30
Fidelity Concord Street…0%11 2722026-07-31